JPS5828296A - Preparation of s-adenosylmethionine - Google Patents
Preparation of s-adenosylmethionineInfo
- Publication number
- JPS5828296A JPS5828296A JP12416681A JP12416681A JPS5828296A JP S5828296 A JPS5828296 A JP S5828296A JP 12416681 A JP12416681 A JP 12416681A JP 12416681 A JP12416681 A JP 12416681A JP S5828296 A JPS5828296 A JP S5828296A
- Authority
- JP
- Japan
- Prior art keywords
- genus
- adenosylmethionine
- medium
- amino acid
- methionine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
本発明はfIII#法による8−アデノシルメチオニン
(以下、8AMと略称する)の驕遣方法に関し、更に詳
しくは、非硫黄系アミノ酸またはその塩を添加したメチ
オニン含有液体培地中で酵母を培養し、8ム菖を効率的
に製造する方法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for enriching 8-adenosylmethionine (hereinafter abbreviated as 8AM) by the fIII# method, and more specifically, to a method for producing 8-adenosylmethionine (hereinafter abbreviated as 8AM) using a methionine-containing liquid containing a non-sulfur amino acid or a salt thereof. The present invention relates to a method for cultivating yeast in a medium and efficiently producing 8-musume irises.
8ムMは生体内において脂肪、蛋白質、糖類などの代−
に関与する重要な物質である◎而して近時かかる8ムM
に肝血症、過度脂血症、動啄硬化症、抑うつ病および神
経病形の精神病発現、変性間接症神経病痛覚、不眠症な
どに対する治療効果のあることが見い出されており、そ
の大量生産が期待されている〇
従来1.aAMの製造方法としては種々の微生物を用い
る培養法が知られているが、なかでも酵母を用いる方法
が好ましいとされておシ、その具体例としてサツカロマ
イセス属またはキャ/デイダ属の微生物を用いる方法(
例えばJournal ofBaet・r4G1GBy
、マOX 121.267頁(1975年)など)、ビ
ヒア属、ロドトルラ属、クリプトコツカスj1%ハンゼ
ヌラII、 )リコスボロン属、フレケラ属、ハ/ゼ
ニアスボ之属、スボロボロゼセス属、リボ(セス属ま九
はデバリオミセス属の黴生物τ用いる方法(特公昭52
−17118号)などが知られている。しかしながら、
これらの方法においてもSAMc)蓄積型は必ずしも充
分洒足できるものとはいえず、より一層の改良が求めら
れていた。8M is a substitute for fats, proteins, sugars, etc. in the body.
It is an important substance involved in
It has been found that it has a therapeutic effect on hepatemia, hyperlipidemia, kinetosclerosis, depression and neurological forms of psychosis, degenerative arthritis, neurological pain sensation, insomnia, etc., and its mass production. It is expected that 〇Conventional 1. Cultivation methods using various microorganisms are known as methods for producing aAM, but among them, methods using yeast are said to be preferred, and a specific example thereof is a method using microorganisms of the genus Satucharomyces or Ca/Deida. (
For example, Journal ofBaet・r4G1GBy
, MaOX p. 121.267 (1975), etc.), Bichia, Rhodotorula, Cryptococcus j1% Hansenula II, ) Lycosboro, Frechella, Ha/Xeniasbo, Sboroborozes, Ribo (Ses) is a method using the fungal organism τ of the genus Debaryomyces (Special Publication No. 52
-17118) are known. however,
Even in these methods, the SAMc) accumulation type cannot necessarily be said to be sufficiently efficient, and further improvements have been desired.
そこで木兄#4Jらはai#al法にょるSAMの蓄積
1同Fにつき鋭意検討を加えた結果、HAMの前駆体で
あるメナオニ/とともにアミノ酸を添加した培j11i
I5r用いることが有効であることを見い田し、本発明
を完成した。Therefore, as a result of intensive investigation into the accumulation of SAM by the ai#al method, Kinei #4J et al.
They found that using I5r was effective and completed the present invention.
すなわち本発明の目的は生産能に優れた発酵法によるH
AM(Q製造方法を提供することにあり、かかる本発明
の目的は、BAM生m能を有する酵母をメナオニン含有
培地で@誉してBAMを製造する方法rcおいて、分子
中に硫黄原子を含゛まない非硫黄系アi)酸筐たはその
塩を培地に添加することにより達成される。That is, the purpose of the present invention is to produce H using a fermentation method with excellent productivity.
The purpose of the present invention is to provide a method for producing AM (Q), and an object of the present invention is to provide a method for producing BAM by culturing yeast capable of producing BAM in a menaonin-containing medium, in which sulfur atoms are added to the molecule. This can be achieved by adding a non-sulfur-based a) acid or its salt to the medium.
本発明において用いられる#母はメチオニン含有培地中
で8ムMを蓄積する能力1r有するものであればいずれ
でもよいが、な〃・でもサツカロ・ンイセ/’C(Q−
c−c、懸aruシc門)X、ギヤ/ディグ(,9an
曹) f4、ハンセヌラ(HaΩS・Ω−1−) Mに
属する#母が好ましく、その具体へとしてサツカロマイ
セス・セレビジェエF0 2546、キャンディダ・マ
キドニエ/シスエFl’0 0960.ハンセヌラ・フ
ァビアニイ エll’0 1570 などが皐けられ
る。′またこれらの天然及び人工変異−であって奄8A
M生産能を有するがぎり同様に使用することができる。The #mother used in the present invention may be any mother as long as it has the ability to accumulate 8M in a methionine-containing medium, but it is not limited to
c-c, arushi cmon)X, gear/dig (,9an
(Ca) f4, Hansenula (HaΩS・Ω-1-) #mother belonging to M is preferable, and its specific examples include Satucharomyces cerevisiae F0 2546, Candida machidoniae/Sisue Fl'0 0960. Hansenula Fabianii El'0 1570 etc. are being criticized. 'Also, these natural and artificial mutations-
It can be used in the same way as a gagiri with M production capacity.
本発明においては、メナオニン含有培地中ニ非硫黄系ア
ミノ酸ま九はその塩を添加することが必須の要件である
。ここでいう非硫黄系アミノ酸とは分子中に硫★原子を
含まないアミノrI&をさし、その其体伺としてグリシ
/、メチルグリシン、L−アラニン、L−ロイ7ン、L
−イソロイジノ、D、 L−バリン、β−アラニノ、D
、 L−α−アミノ−に−m#、n1L−β−7ミ/−
ri−am、L−セリン、L−スレオニン、L−ホモセ
リン、r−アミノーβ−ヒドロキシ−路−Mgl!など
のごとき中性の脂肪族系アばノ緻;L−アスパラギ/[
%L−グルタミン酸などのごと1!酸性の脂肪族系アミ
ノ酸;L−アルギニン、L−リジン、L−オルニチン、
L−アスパラギア、 L−グルタミンなどノコとき塩基
性の脂肪族系アミノ酸;L−プロリン、L−ヒステジ/
、ヒドロキシ−L−プロリンなどのごとき複素1系アミ
ノ酸;L−7エニルアラニン、L−テロシフ、L−トリ
ットファンなどのごとき芳香族系アミノ酸などが例示さ
れる。またこれらの塩としてはアルカリ金属塩、塩緻塩
などがカ示される。これらの非硫黄系アミノ酸は通常培
地中に[lQ 211/C1t以上の濃度で添加され、
とくに0−041/d1以上の濃度とするのが適切であ
る。In the present invention, it is essential to add a salt of the non-sulfur amino acid to the menaonin-containing medium. The non-sulfur amino acids referred to here refer to amino rI&, which does not contain a sulfur atom in the molecule, and its examples include glycine/, methylglycine, L-alanine, L-leucine, and L-alanine.
-isoloidino, D, L-valine, β-alanino, D
, L-α-amino-ni-m#, n1L-β-7mi/-
ri-am, L-serine, L-threonine, L-homoserine, r-amino-β-hydroxy-Mgl! Neutral aliphatic amines such as L-asparagi/[
%L-glutamic acid etc. 1! Acidic aliphatic amino acids; L-arginine, L-lysine, L-ornithine,
L-asparagia, basic aliphatic amino acids such as L-glutamine; L-proline, L-hysteresis/
, hydroxy-L-proline, and the like; aromatic amino acids such as L-7 enylalanine, L-telosif, L-tritophane, and the like. Examples of these salts include alkali metal salts and salts. These non-sulfur amino acids are usually added to the culture medium at a concentration of [1Q211/C1t or higher,
In particular, it is appropriate to set the concentration to 0-041/d1 or more.
本発明で用いる培地の他の条件は常法に従えばよく、偽
えば脚g源としてグルコース、7ユクロース、79クト
ース等の楯類、酢酸などの有機酸類、炭化水素類、メタ
ノール、エタノールナトのアルコール類などを用いるこ
とができる0ま九培地中には更に通常の窒素源、無rr
a塩、有機微量栄養素が必要に応じて使用される。Other conditions for the culture medium used in the present invention may be determined according to conventional methods, including glucose, 7-ucrose, 79-ctose, and other shields, organic acids such as acetic acid, hydrocarbons, methanol, and ethanol. In addition, a normal nitrogen source, no rr
a-salts, organic micronutrients are used as needed.
培養は好気的条件が良く、培養温度は2υC力・ら40
Cの範囲が好ましい。培養の喚、培地のPHを6から8
の範囲にm穎すれば通常最も望ましい結果が得られる。The culture is carried out under good aerobic conditions, and the culture temperature is 2υC・ra40
A range of C is preferred. When culturing, adjust the pH of the medium from 6 to 8.
The most desirable results will usually be obtained if the temperature is within the range of .
かくして培養2日から10日後には一体中および/又は
培養液中にE3AMが生成蓄積するので、これを常法に
従って処理することによシRAMを取得することができ
る。Thus, after 2 to 10 days of culture, E3AM is produced and accumulated in the cells and/or the culture solution, and RAM can be obtained by processing this in a conventional manner.
例えばEIAM官有一体を過塩素酸で抽出し、抽出液を
水冷下に炭酸水素カリウムで中和したのち、必資に応じ
て強嘔性カチオン父換樹脂に接触させ、次いで8ムMi
吸層したのち硫酸で溶出し、俗出液にリンタングステア
#lt加えてSAMを沈澱させることによって単離する
ことができる。For example, EIAM monomers are extracted with perchloric acid, the extract is neutralized with potassium bicarbonate under water cooling, and then brought into contact with a strong cationic father-converting resin as required, and then 8 μM Mi
After absorbing the layer, it is eluted with sulfuric acid, and SAM can be isolated by adding phosphotungstair #lt to the effluent to precipitate it.
以下に実施ガを皐げて本発明をさらに具体的に説明する
0ただし、本発明はこれに限定されるものではない。な
お、実施例におけるBAMの定菫は次のようにり、−u
行つた。すなわち、培養終了犠、遠心分離にて一体とm
*献を分離し、一体金約5−重の15M過塩素ばで抽出
した。次いで得られた抽出上置液t−培髪液と混合した
のち、ペーパークーントグラフイ−(展8浴媒:エタノ
ール/1−ブタノール/水/酢鍼/1%ピロリン酸ナト
リウム水溶液−55150150/1/1 )で分離し
、紫外縁検出器でSAM相尚のスポットを検出し、これ
をα1M塩酸で抽出して、その260%fiの吸光度よ
プ賦科中の511M量を検出し丸。The present invention will be described in more detail below with reference to examples of implementation. However, the present invention is not limited thereto. In addition, the constant violet of BAM in the example is as follows, -u
I went. In other words, after culturing is completed, the m
*The fraction was separated and extracted with a 15M perchlorine solution containing approximately 50% of the total gold. Then, after mixing with the obtained extraction supernatant solution T-hair culture solution, paper coutonography (Example 8 Bath medium: ethanol/1-butanol/water/vinegar acupuncture/1% sodium pyrophosphate aqueous solution-55150150/1 /1), a spot of the SAM phase was detected with an ultraviolet edge detector, extracted with α1M hydrochloric acid, and the amount of 511M in the sample was detected from its 260% fi absorbance.
実施例1
/ h コ−ス51 /(11、ホリヘフ) ンa51
/lit。Example 1 / h Course 51 / (11, Horihef) N a51
/lit.
KH2PO4(lL41/dl、 KH2O4CL41
/dt、 Mg804・7 H20α11/dl%#母
エキス 0.21/(tl、 yIA犬217dlから
なる寒天斜面培地(pIito)に2日間生育させたサ
ツカロマイセス・セレビジエエFO2546の1白金耳
を、ンユクロース 1017dl。KH2PO4 (lL41/dl, KH2O4CL41
/dt, Mg804.7 H20α11/dl% #Mother extract 0.21/(tl, yIA Dog) 1 platinum loop of Satucharomyces cerevisiae FO2546 grown for 2 days on an agar slant medium (pIito) consisting of 217 dl was mixed with 1017 dl of Nucrose.
#母エキス11/d1%KH2PO4L417QLe、
MgBua ・7 Hz OQ、011/dz、尿;
1c(別滅−) t51/dl。#Mother extract 11/d1%KH2PO4L417QLe,
MgBua ・7 Hz OQ, 011/dz, urine;
1c (not listed separately) t51/dl.
L−メチオー/(J、751/dl%a*ct2・2H
200−021/dl、 ZnBOa ・7H20CL
25tsl/dl、 FeSO4・7)(20α25m
1/lt1%MnSO44〜6 Hz0 t25a&
I/de%Cu1304・5H202μl/dl、 H
4BOs2μl/≦it、 a ・)v12 ・6
H20α2μl/dt、 XI 1 μkl/d
4テ及び所定量のグリシノからなりPHAOに14整、
加熱滅菌した培地5dに檀−し、28Cで5日間振敵し
た。次いでSAMの蓄積i1を量定し、結果を第1表に
示した。L-methio/(J, 751/dl%a*ct2・2H
200-021/dl, ZnBOa ・7H20CL
25tsl/dl, FeSO4・7) (20α25m
1/lt1%MnSO44~6 Hz0 t25a&
I/de%Cu1304・5H202μl/dl, H
4BOs2μl/≦it, a ・)v12 ・6
H20α2 μl/dt, XI 1 μkl/d
PHAO consists of 4 te and a predetermined amount of glycino, and 14 te,
The cells were placed in heat-sterilized medium 5d and shaken at 28C for 5 days. The SAM accumulation i1 was then quantified and the results are shown in Table 1.
第1表
この結果から、グリシ/を添加することによりSAMO
生g量を向上させうることがわかる。Table 1 From this result, SAMO can be
It can be seen that the amount of raw g can be improved.
実施例2
グリシ/のかわりに@2表に示1′アミノ販をα11/
dl 0tIIk度で培地VC添加すること以外は実
m?111と同じ条件で培養を行つ友。結果′に第2表
に示した〇
実jIIガ5
ナツカロマイセス・セレビシェ エ1!102546の
代シに第5表に示す一株を用い、かつα11/llの各
種アミノat−培地に添加すること以外は実施例1と同
じ条件で培養を行った。結果を$5表に示した6
第3表Example 2 Instead of Glyshi/1'amino sales shown in @2 table, α11/
Real m except for adding medium VC at dl 0tIIk degree? A friend that performs cultivation under the same conditions as 111. In the results, one strain shown in Table 5 was used as a substitute for Natsucalomyces cerevisiae 1!102546 shown in Table 2, and other than adding it to α11/ll of various amino at-medium. Culture was performed under the same conditions as in Example 1. The results are shown in the $5 table 6 Table 3
Claims (1)
チオニ/含有培地で培養して8−アデノシルメチオニ/
を製造する方法において、分子中Kil*I[子を含ま
ない非硫黄系アミノ酸ま九はその塩を培地に添加するこ
とを特徴とする8−アデノシルメチオニ/の製造方法@ 2 #母がサツカロマイセス属、キャ/デイダ属を友は
ハ/ゼヌツ属に属するものである**−求め範I!第1
項記載の方法0 五 培地中O非硫黄系アミノ酸ま九社その塩(2)11
度がα021/lie以上である%IFFM求の範囲纂
1JJi記載の方法、。[Claims] t A yeast having the ability to produce 8-adenosylmethionine is cultured in a medium containing methionine/8-adenosylmethionine/
A method for producing 8-adenosylmethioni/, characterized in that the molecule Kil*I [non-sulfur amino acid that does not contain offspring, and its salt] is added to the culture medium. The genus Satucharomyces and the genus Ca/Deida belong to the genus Ha/Zenuts **-Searching range I! 1st
Method described in Section 0 5. O non-sulfur amino acids in the medium Makusha Salt (2) 11
The method described in Range Collection 1JJi for determining %IFFM where the degree is α021/lie or more.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12416681A JPS5828296A (en) | 1981-08-10 | 1981-08-10 | Preparation of s-adenosylmethionine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12416681A JPS5828296A (en) | 1981-08-10 | 1981-08-10 | Preparation of s-adenosylmethionine |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS5828296A true JPS5828296A (en) | 1983-02-19 |
Family
ID=14878574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12416681A Pending JPS5828296A (en) | 1981-08-10 | 1981-08-10 | Preparation of s-adenosylmethionine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5828296A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5082288A (en) * | 1973-11-27 | 1975-07-03 |
-
1981
- 1981-08-10 JP JP12416681A patent/JPS5828296A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5082288A (en) * | 1973-11-27 | 1975-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI235177B (en) | L-glutamic acid-producing bacterium and method for producing L-glutamic acid | |
AU2009232936B2 (en) | Yeast mutant and yeast extract | |
JPS63500004A (en) | Method for preparing optically active organic compounds | |
FR2459832A1 (en) | PROCESS FOR PRODUCING L-HISTIDINE BY FERMENTATION | |
FR2480306A1 (en) | PROCESS FOR THE PRODUCTION OF L-METHIONINE BY FERMENTATION | |
JPS60118196A (en) | Production of interferon | |
JPH01503676A (en) | Total protein - breakdown products | |
FR2701489A1 (en) | Process for the production of L-glutamic acid by fermentation | |
JPS58179497A (en) | Preparation of l-histidine by fermentation | |
JPS5828296A (en) | Preparation of s-adenosylmethionine | |
Subbarow et al. | Pantothenic acid as a factor in rat nutrition | |
JPS61242589A (en) | Production of l-sulfur-containing amino acid | |
JP4620404B2 (en) | Yeast mutant, method for producing yeast having high glutathione content, culture thereof, fraction thereof, yeast extract, and food and drink containing glutathione | |
JP2832723B2 (en) | Method for producing L-alanine | |
EP1429716A2 (en) | Cosmetic preparation with anti-wrinkle action | |
AU2014256403B2 (en) | Yeast mutant and yeast extract | |
JP2974074B2 (en) | Growth promoter | |
Jwanny et al. | Assimilation of methanol by yeasts | |
JPS61139397A (en) | Production of l-serine | |
Clemens | Influence of amino acid supply on protein synthesis by rat liver in vitro. | |
Lorkiewicz | Effects of incorporation of iododeoxyuridine on Escherichia coli | |
JP3603330B2 (en) | Method for producing amino acid polycondensate | |
JPS63295A (en) | Production of nicotinamide adenine dinucleotide | |
CS135490A3 (en) | Source of proteins containing other essentially biologically active compounds for nutritive purposes, particularly for feeding animals and process for preparing thereof | |
JPH0611232B2 (en) | Method for producing L-sulfur-containing amino acid |